Home›Incobotulinumtoxina›Incobotulinumtoxina + Botulinum Toxin Type A

Does Incobotulinumtoxina Interact with Botulinum Toxin Type A?

Incobotulinumtoxina and Botulinum Toxin Type A have a major drug interaction according to U.S. FDA drug labeling data. Administration of different botulinum toxin products at the same time or within several months may exacerbate excessive neuromuscular weakness. The mechanism involves additive neuromuscular effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Incobotulinumtoxina Class
Acetylcholine Release Inhibitor
Botulinum Toxin Type A Class
Acetylcholine Release Inhibitor
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Incobotulinumtoxina and Botulinum Toxin Type A occurs because additive neuromuscular effects. Clinically, this means administration of different botulinum toxin products at the same time or within several months may exacerbate excessive neuromuscular weakness. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Incobotulinumtoxina and your doctor is considering prescribing Botulinum Toxin Type A (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Incobotulinumtoxina(Xeomin)+💊 Botulinum Toxin Type A(Dysport)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Acetylcholine Release Inhibitor
Drug B class
Acetylcholine Release Inhibitor
Source
NLP:incobotulinumtoxina

What this means in plain English

Administration of different botulinum toxin products at the same time or within several months may exacerbate excessive neuromuscular weakness.

About Incobotulinumtoxina and Botulinum Toxin Type A

Incobotulinumtoxina and Botulinum Toxin Type A both belong to the Acetylcholine Release Inhibitor class. You may recognize them by the brand names Xeomin and Dysport. Both medications are given by intramuscular injection. Both Incobotulinumtoxina and Botulinum Toxin Type A carry an FDA boxed warning — the agency's most serious safety designation.

What the FDA label says

"Additive neuromuscular effects"

📖 Source: NLP:incobotulinumtoxina

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Incobotulinumtoxina and Botulinum Toxin Type A against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.